These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19455069)

  • 1. Short-term (1-2 mo) hormone therapy cessation before mammography.
    Reed SD; Buist DS; Anderson ML; Bowles EJ; Fitzgibbons D; Seger D; Newton KM
    Menopause; 2009; 16(6):1125-31. PubMed ID: 19455069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.
    Kerlikowske K; Cook AJ; Buist DS; Cummings SR; Vachon C; Vacek P; Miglioretti DL
    J Clin Oncol; 2010 Aug; 28(24):3830-7. PubMed ID: 20644098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension.
    Aiello Bowles EJ; Anderson ML; Reed SD; Newton KM; Fitzgibbons ED; Seger D; Buist DS
    J Womens Health (Larchmt); 2010 Aug; 19(8):1467-74. PubMed ID: 20575711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
    Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
    JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.
    Chlebowski RT; Hendrix SL; Langer RD; Stefanick ML; Gass M; Lane D; Rodabough RJ; Gilligan MA; Cyr MG; Thomson CA; Khandekar J; Petrovitch H; McTiernan A;
    JAMA; 2003 Jun; 289(24):3243-53. PubMed ID: 12824205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.
    Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
    Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of hormone therapy and isoflavones and mammographic density in Spain.
    Isidoro B; Lope V; Whelan D; Pedraz C; Sánchez-Contador C; Santamariña C; Moreo P; Vidal C; Salas-Trejo D; Ederra M; Aragonés N; Pérez-Gómez B; Pollán M
    Menopause; 2016 May; 23(5):556-64. PubMed ID: 26731688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term hormone therapy suspension and mammography recall: a randomized trial.
    Buist DS; Anderson ML; Reed SD; Aiello Bowles EJ; Fitzgibbons ED; Gandara JC; Seger D; Newton KM
    Ann Intern Med; 2009 Jun; 150(11):752-65. PubMed ID: 19487710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States).
    Aiello EJ; Buist DS; White E
    Cancer Causes Control; 2006 Dec; 17(10):1227-35. PubMed ID: 17111253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen plus progestin and risk of benign proliferative breast disease.
    Rohan TE; Negassa A; Chlebowski RT; Lasser NL; McTiernan A; Schenken RS; Ginsberg M; Wassertheil-Smoller S; Page DL
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2337-43. PubMed ID: 18725513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
    Hofvind S; Møller B; Thoresen S; Ursin G
    Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen-progestin and estrogen on mammographic density.
    Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
    J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy and breast cancer risk.
    Foidart JM; Desreux J; Pintiaux A; Gompel A
    Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisen A; Lubinski J; Gronwald J; Moller P; Lynch HT; Klijn J; Kim-Sing C; Neuhausen SL; Gilbert L; Ghadirian P; Manoukian S; Rennert G; Friedman E; Isaacs C; Rosen E; Rosen B; Daly M; Sun P; Narod SA;
    J Natl Cancer Inst; 2008 Oct; 100(19):1361-7. PubMed ID: 18812548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.